- About us
- About Vaccines
- Media centre
- Become a member
The frequency of antimicrobial resistance (AMR) is increasing in Europe and constitutes a serious danger to public health. Evidence has shown that existing vaccines have a positive impact in reducing AMR. In addition, new vaccines could play a critical role in preventing multi-drug resistant infections, such as from S. aureus, C. difficile and E. coli.
Access and download our paper here.
Vaccine-preventable diseases have significant impacts on adult mortality, health and quality of life. Adult vaccination has been given less emphasis than other health priorities and its benefits to societies are not as well recognised. Current national vaccination recommendations focusing on childhood vaccines need to be expanded to ensure opportunities for other population groups, such as adults and particularly those ages 65 and older, who are at highest risk for many infections.
Vaccines Europe calls on public health authorities to set up a structured dialogue/platform bringing together all stakeholders with the objective of establishing a roadmap for putting at the top of national agendas a life-long vaccination approach in Europe, as proposed in the Council conclusions on vaccinations as an effective tool in public health. Our position paper can be accessed here.
The European Scientific Working group on Influenza (ESWI) is hosting the sixth edition of its ESWI Influenza Conferences in Riga, Latvia, on 10–13 September 2017. Over the past years, the ESWI Influenza Conferences have grown into the largest European scientific conferences entirely dedicated to influenza. Read more…